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Interleukin 2-inducible T cell kinase (ITK) inﬂuences T cell signaling by coordinating actin polymeriza-
tion and polarization as well as recruitment of kinases and adapter proteins. ITK regulates multiple
steps of HIV-1 replication, including virion assembly and release. Fluorescent microscopy was used to
examine the functional interactions between ITK and HIV-1 Gag during viral particle release. ITK and
Gag colocalized at the plasma membrane and were concentrated at sites of F-actin accumulation and
membrane lipid rafts in HIV-1 infected T cells. There was polarized staining of ITK, Gag, and actin
towards sites of T cell conjugates. Small molecule inhibitors of ITK disrupted F-actin capping, perturbed
Gag-ITK colocalization, inhibited virus like particle release, and reduced HIV replication in primary
human CD4þ T cells. These data provide insight as to how ITK inﬂuences HIV-1 replication and suggest
that targeting host factors that regulate HIV-1 egress provides an innovative strategy for controlling
HIV infection.
& 2012 Elsevier Inc. All rights reserved.Introduction
The HIV-1 group-speciﬁc antigen (Gag) protein is necessary
and sufﬁcient for the formation of virus like particles (VLPs)
(Gheysen et al., 1989). Virus assembly is a multistep process
which includes Gag transport to the site of assembly, binding to
the lipid bilayer, multimerization, budding and pinching off of the
viral particle from the host membrane. In infected T cells Gag
polyproteins (Pr55Gag) are targeted to the plasma membrane
(Freed, 1998; Garnier et al., 1998; Tritel and Resh, 2000) where
they preferentially localize at lipid rafts and assemble into
immature viral particles (Garoff et al., 1998). The HIV-1 Gag
matrix (MA) domain is required for Gag targeting to the plasma
membrane (Spearman et al., 1994). Critical regions within the MA
domain that mediate membrane targeting include N-terminus
myristylation signals and the highly basic domain, which directsll rights reserved.
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Henderson).Gag to rafts enriched with phosphatidylinositol-(4,5)-bispho-
sphate (PI(4,5)P(2)) (Saad et al., 2008, 2007, 2006; Zhou et al.,
1994). Deleting or mutating the highly basic domain alters the
cellular distributions of Gag away from the plasma membrane
and into intracellular compartments such as the endoplasmic
reticulum, late endosomes or MVBs (Facke et al., 1993; Ono et al.,
2004; Ono and Freed, 2004; Zhou and Resh, 1996). Identifying
cellular factors that coordinate and regulate Gag trafﬁcking and
intracellular localization would provide insights into mechanisms
for this critical step in HIV-1 replication as well as suggest
potential strategies to block late stages of HIV egress.
Productive HIV-1 infection in T cells requires T cell activation
(Oswald-Richter et al., 2004; Stevenson et al., 1990) and reorganiza-
tion of the cytoskeleton (Fackler and Krausslich, 2006; Gladnikoff
et al., 2009; Jolly et al., 2004; Vorster et al.). Interleukin-2 inducible T
cell kinase (ITK) modulates T cell signaling (Andreotti et al.) by
coordinating changes in cellular organization during T cell activation
(Gomez-Rodriguez et al., 2007), including accumulation of F-actin at
sites of receptor engagement or within immunological synapses.
Studies performed with T cells lacking ITK show defects in actin
responses including extending unstable lamellipodia upon T cell
receptor (TCR) stimulation (Berge et al., 2010; Carrizosa et al., 2009),
an inability to properly polarize upon contact with antigen present-
ing cells (Labno et al., 2003), and reduced accumulation of activated
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2005). ITK is activated and targeted to the plasma membrane
downstream of TCR signaling and chemokine receptor CXCR4
signaling induced by SDF1a (Fischer et al., 2004). Since these
receptors are utilized by HIV-1 to gain access into target cells and
T cell activation is necessary for efﬁcient HIV-1 replication, we posit
that ITK impacts HIV-1 replication.
We recently demonstrated that ITK facilitates HIV-1 replica-
tion and is necessary for efﬁcient viral entry, proviral transcrip-
tion, and viral particle assembly and release (Readinger et al.,
2008). In this study, we utilize wide ﬁeld ﬂuorescence deconvolu-
tion microscopy to gain a better understanding of mechanisms by
which ITK enhances viral particle assembly and release. Our
ﬁndings show that ITK and Gag colocalize at sites of actin
polymerization and membrane lipid rafts. Chemical inhibition of
ITK disrupts actin capping, perturbs Gag-ITK colocalization and
correlates with decreased virus like particle release. Our ﬁndings
demonstrate that ITK is a potential novel drug target for inhibiting
HIV assembly and release in infected T cells.Fig. 1. ITK-mediated enhancement of VLP release requires Gag targeting to the
plasma membrane. (a) HEK293T cells were transiently transfected with Gag-
Cherry, or DMA Gag-Cherry DNA plus vector-GFP (control) or ITK-GFP DNA
constructs. Supernatants were spun on 20% sucrose cushion to purify extracellular
virus like particles and assayed by p24 ELISA. p24 values were normalized to Gag
associated with whole cell extracts as determined by immunoblots and denis-
trometry (b). These data are from a single transfection experiment performed in
triplicate and represent greater than three independent experiments. Error bars
show the standard deviation between the triplicate transfections for each condi-
tion. n indicates a P value o0.05 as determined by a Student’s t-test.Results
ITK and Gag colocalize at the plasma membrane in distinct lipid
raft microdomains
We have shown that ITK facilitates VLP production and that
the PH and SH2 domains of ITK are critical for this function
(Readinger et al., 2008). To begin to investigate how ITK regulates
VLP assembly and whether it inﬂuences Gag trafﬁcking, we
utilized a Gag mutant, DMA(16–99), which has a deletion in the
highly basic region of MA domain. Although this mutation does
not prevent VLP release (Supplemental Fig. 1), DMA Gag does not
bind PIP2 and is diverted from the plasma membrane, preferen-
tially targeting intracellular compartments, such as ER and
endosomal vesicles (Facke et al., 1993; Hermida-Matsumoto and
Resh, 2000; Ono and Freed, 2004; Ono et al., 2000; Yuan et al.,
1993). To determine if ITK was able to enhance DMA Gag VLP
production, we transfected HEK293T cells with plasmids expres-
sing ITK-GFP fusion protein and Gag-Cherry or DMA Gag-Cherry
fusion proteins. The ﬂuorescent tags were used to assess the
expression of transfected proteins and determine their intracel-
lular localization by immunoﬂuorescence microscopy. VLP release
was determined by measuring p24gag in transfected cell super-
natants by ELISA, while immunoblots of whole cell lysates
conﬁrmed Gag, DMA Gag, and ITK expression. ITK enhanced VLP
release by greater than 7 fold when cotransfected with Gag-
Cherry (Fig. 1a) consistent with our previous ﬁndings (Readinger
et al., 2008), whereas ITK did not facilitate release of DMA Gag
VLPs. Western blot analysis conﬁrmed that comparable levels of
Gag or DMA Gag were expressed in the absence or presence of ITK
(Fig. 1b). These data suggest that ITK does not inﬂuence Gag
trafﬁcking but enhances VLP release after Gag has been delivered
to the plasma membrane.
We used deconvolution microscopy to visualize the location of
ITK and Gag and determine if they colocalized at the plasma
membrane. ITK was observed dispersed throughout the plasma
membrane when ITK-GFP was overexpressed in HEK293T cells
(Fig. 2a). In contrast, mPH-ITK, which harbors a point mutation
within the Pleckstrin Homology (PH) domain that disrupts the
ability of ITK to bind PIP3, is redirected from the plasma
membrane to intracellular compartments. Similarly, Gag-Cherry
was expressed throughout the plasma membrane, whereas, DMA
Gag-Cherry was redirected from the plasma membrane and into
intracellular compartments consistent with previously described
patterns for HIV-1 Gag and DMA Gag (Hermida-Matsumoto andResh, 2000; Ono and Freed, 2004; Ono et al., 2000; Yuan et al.,
1993). When ITK and Gag were co-expressed we observed that in
100% of the cells ITK and Gag colocalized within the plasma
membrane with an average of Pearson’s coefﬁcient r¼0.87, often
in distinct domains, which were observed in approximately 45%
of the cells (Fig. 2b), whereas, capping or clustering of Gag-cherry
was not observed in cells expressing only Gag-cherry (Fig. 2a).
Coexpressing mPH-ITK with Gag did not result in capping of Gag
(Fig. 2b) indicating that the ITK PH domain and membrane
targeting are required for the ability of ITK to inﬂuence Gag
distribution. In addition, ITK was not able to redirect DMA Gag
from intracellular compartments to the plasma membrane
(Fig. 2c). Coexpressing mPH-ITK and DMA Gag resulted in both
molecules targeting distinct intracellular compartments. These
data suggest that although Gag and ITK can independently trafﬁc
to the plasma membrane, once at the membrane they functionally
interact to form distinct domains where they colocalize.
To conﬁrm ITK and Gag colocalize in the context of infected T
cells, we visualized the location of endogenous ITK and Gag in
Fig. 2. ITK colocalizes with Gag at the plasma membrane in transfected HEK293T cells. (a) HEK293T cells were cotransfected with (a)–(c) Gag-Cherry, DMA Gag-Cherry,
ITK-GFP, or mPH-ITK-GFP (which lacks a functional pleckstrin homology domain). Cells were ﬁxed and viewed using a Nikon Fluorescence microscope at 60 oil
immersion, Image J software was used for deconvolution and image analysis.
G.M. Schiralli Lester et al. / Virology 436 (2013) 235–243 237HIV-1 infected Jurkat T cells. Gag expression was predominantly
detected at the plasma membrane of HIV-1 infected T cells
(Fig. 3a), often in discrete patches or caps. Consistent with the
above ﬁndings, ITK staining overlapped with Gag staining sug-
gesting that Gag and ITK are found in similar plasma membrane
lipid domains (average Pearson’s coefﬁcient measures r¼0.93).
This was further explored by determining if ITK and Gag were
targeting cholesterol rich lipid raft regions. Infected Jurkat T cells
were stained with FITC-conjugated cholera toxin B which binds
GM1 a component of lipid rafts, as well as, anti-Gag and anti-ITK
antibodies. As shown in Fig. 3b, Gag and ITK were present at
regions that stained with cholera toxin B, indicating that in HIV
infected cells Gag and ITK colocalize in lipid raft microdomains
(for Gag and CT-B staining average Pearson’s coefﬁcient measures
r¼0.813, for ITK and CT-B staining average Pearson’s coefﬁcient
measures r¼0.736).Gag, ITK, and F-actin accumulate at sites of T cell contact
HIV particle transfer via cell-to-cell contact is more efﬁcient
than infection by cell-free virions (Carr et al., 1999; Dimitrov
et al., 1993; Phillips, 1994). This is in part due to a redistribution
of Gag and a directional release of HIV-1 towards the uninfected
target cell (Johnson and Huber, 2002). This capping of Gag is
associated with localized changes to the cytoskeleton including
actin polymerization (Jolly et al., 2004). Therefore, we examined
the distribution of ITK, Gag and actin during HIV infection
especially in juxtaposed T cells. As expected, we observed Gag
capping in HIV-1 infected cells directed towards the neighboring
cell (Fig. 3c). ITK is also polarized, colocalizing with Gag at regions
where T cells are in close proximity (average Pearson’s coefﬁcient
measures r¼0.67). Similarly, F-actin, as detected by staining cells
with Phalloidin, accumulated at sites where T cells were in close
proximity or in contact and colocalized with ITK (Fig. 4; average
Pearson’s coefﬁcient measures r¼0.89). These data indicate thatITK, Gag and F-actin are located in overlapping and discrete regions in
T cell-T cell conjugates.
Compounds that inhibit ITK diminish VLP release, alter Gag-ITK
colocalization at the plasma membrane and disrupt actin
polymerization
We were interested in determining whether compounds that
targeted ITK activity could be used to block HIV-1 assembly and
release. We performed VLP assays by cotransfecting Gag and ITK
in the presence or absence of ITK inhibitors BMS509744 or
CNX-225. BMS509744 is a chemical inhibitor which speciﬁcally
inhibits ITK activation (Lin et al., 2004) and CNX-225 is a selective
small molecule kinase inhibitor that covalently binds Tec kinases.
CNX-225 structure and proﬁle for inhibition of Tec kinase family
members are shown in supplemental Fig. S2. ITK enhanced VLP
production by greater than 5 fold (Fig. 5a) in DMSO treated
control samples, consistent with the above data (Fig. 1a) and
our previous report (Readinger et al., 2008). Induction of VLPs was
not observed in cells treated with either inhibitor suggesting that
speciﬁc chemical inhibitors reduce the ability of ITK to facilitate
HIV assembly and release. In order to determine whether the ITK
inhibitor CNX-225 inhibited HIV replication in human primary
CD4þ T cells, HIV infected cells were treated with the inhibitor
24 h post HIV infection. CNX-225 reduced HIV replication by
approximately 70% compared to the DMSO vehicle control treat-
ment (Fig. 5b). These results are similar to our previous ﬁndings
which showed that BMS509744 inhibited HIV replication in
primary human CD4þ T cells (Readinger et al., 2008).
Since ITK inﬂuenced Gag membrane location and cytoskeleton
organization, we were interested in determining if the ITK
inhibitors altered Gag and actin distribution. Infected Jurkat T
cells were treated with BMS509744 or CNX-225. Deconvolution
microscopy was employed to visualize how these compounds
inﬂuenced intracellular distribution of ITK, Gag and F-actin. As
expected in DMSO treated controls ITK and Gag colocalized at the
Fig. 3. ITK and Gag colocalize in the plasma membrane in lipid rafts and at sites of T cell-T cell contact in HIV infected T cells. (a) Jurkat cells were infected with VSVG-HXB-
PLAP-nefþ virus, and enriched for HIV infected cells using magnetic beads coated with anti-PLAP antibody. Infected cells were treated with DMSO for 30 min, then ﬁxed,
permeabilized and intracellularly labeled for ITK (green) and Gag (red) expression with speciﬁc antibodies and counterstained with DAPI to detect nuclei (blue). (b) 72 h
post-infection infected Jurkat cells were incubated with cholera toxin B conjugated-FITC, washed and ﬁxed. Cells were permeabilized and intracellularly labeled for ITK
expression (blue) and Gag expression (red). (c) Jurkat cells were infected with VSV-G pseudotyped HXB-PLAP-nefþ virus, treated with DMSO and 72 h post infection cells
were ﬁxed, permeabilized and stained for intracellular ITK (green), Gag (red) and counterstained for DAPI (blue). Cells were imaged using Nikon Fluorescence microscope
at 60 oil immersion, Image J software was used for deconvolution and image analysis.
Fig. 4. ITK colocalizes with actin polymerization in infected T cell conjugates. Jurkat cells were infected with a VSV-G pseudotyped HXB-PLAP-nefþ , and 72 h post
infection cells were sorted for HIV positive cells, ﬁxed, permeabilized and intracellularly labeled for ITK expression (green), Phalloidin (red), and DAPI to detect nuclei
(blue). All images were taken using a Nikon ﬂuorescence microscope at 60 oil immersion, Image J software was used for deconvolution and image analysis.
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r¼0.71). In cells treated with either BMS509744 or CNX-225
ITK inhibitors, ITK was more evenly dispersed throughout the cell
and no longer colocalized with Gag in discrete domains as
indicated in the loss of Pearson’s positive correlative staining
(Fig. 5c and d). ITK and Phalloidin colocalized at sites of cell–cell
contact in vehicle control treated cells (average Pearson’s coefﬁ-
cent measures r¼0.89). However, treating cells with BMS509744
or CNX-225 decreased F-actin polymerization and capping
towards sites of T cell–T cell contact (Fig. 5e). These data indicate
Tec kinase chemical inhibitors diminish the recruitment of ITK
to the plasma membrane perturbing Gag-ITK colocalization,disrupting actin polymerization, and inhibiting HIV release and
replication. Collectively our data demonstrates that targeting ITK
is an effective strategy to inhibit HIV assembly and release.Discussion
In this study, we demonstrate that the ability of ITK to regulate
HIV assembly and release correlates with its function to orches-
trate actin cytoskeleton rearrangements. ITK and Gag colocalize
within cholesterol rich lipid domains in the plasma membrane of
infected T cells; however, ITK does not enhance VLP release of Gag
Fig. 5. Chemical inhibition of ITK disrupts Gag colocalization, alters actin organization, decreases VLP release and inhibits HIV replication. (a) HEK293T cells were co-transfected
with Gag-opt and Vector- eGFP or ITK-eGFP, treated with DMSO, BMS or CNX-225 for 72 h. Supernatants were collected and spun on a 20% sucrose cushion, and assayed by p24
ELISA. p24 values were normalized to Gag associated with whole cell extracts as determined by immunoblots and denistrometry. Fold induction of VLPs over vector control is
shown. This is a single experiment performed in triplicate and represents at least three independent treatments. Error bars calculated as standard deviation and n indicates P
value o0.05 as determined by a Student’s t-test. Immunoblots were also performed to conﬁrm ITK expression. (b) Human primary CD4þ T cells were infected with VSV-G
pseudotyped HXB-PLAP-nefþ virus, 24 h post infection cells were treated with CNX-225 inhibitor (1 mM) or equivalent DMSO and cultured in the presence of treatment for
4 days. Supernatants were sampled at indicated times and HIV replication was assessed by p24 ELISA. These data are triplicate infections from a single donor and are
representative of results obtained from three different donors. The error bars are standard deviation between the triplicate samples and n indicates P valueo0.05 as determined
by a Student’s t-test. (c)–(e) Jurkat cells were infected with a VSV-G pseudotyped HXB-PLAP-nefþ , 72 h post infection cells were sorted for HIV positive cells. HIV positive cells
were treated with BMS509744 (10 mM) or CNX-225 inhibitor (1 mM) or equivalent DMSO control for 30 min. Cells were washed, ﬁxed, permeabilized, and intracellularly labeled
for ITK expression (green) and Gag expression (red). (d) Percent Jurkat cells following treatment in which ITK and Gag staining overlapped. At least 60 cells were counted for each
treatment. (e) HIV infected Jurkat cells were intracellularly labeled for ITK expression (green) and F-actin using Phalloidin (red). The cells were also stained with DAPI to detect
nuclei (blue). Comparable DMSO treated cells are shown in Fig. 4. All images were taken using a Nikon ﬂuorescence microscope at 60 oil immersion, Image J software was used
for deconvolution and image analysis.
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brane to intracellular compartments. These data indicate that physical
proximity to the site of viral particle release is critical for ITK induced
enhancement of VLP release.
ITK and Gag colocalize in discrete membrane domains sug-
gesting that ITK and Gag inﬂuence each other’s distribution in the
plasma membrane. Furthermore, both ITK and Gag are associated
with cholesterol rich rafts which have been described as preferred
sites of virus assembly and release. It is possible that ITK is
physically interacting with Gag at the plasma membrane; ITK has
been shown to interact with many proteins through its SH2-SH3
domains; however, we are unable to coimmunoprecipitate ITK
and Gag (data not shown), suggesting that ITK and Gag indirectly
interact. The functional interaction between ITK and Gag may
be restricted to the plasma membrane since ITK cannot rescue
DMA-Gag localization to plasma membrane or enhance DMA-Gag
VLP release.
Our data suggest that ITK facilitates HIV release by coordinat-
ing actin reorganization. In addition, we observe a high density
of Gag and ITK at sites of dynamic actin polymerization such
as membrane protrusions or extensions (Fig. 2b and data not
shown). For HIV entry and egress the virus must traverse the
barrier presented by cytoskeleton. Inhibitors that block actin and
tubulin assembly or disassembly decrease virus release and
infectivity (Jolly et al., 2004, 2007) highlighting the importance
of the cytoskeleton in HIV replication. Furthermore, cell host
machinery is co-opted to help mediate reorganization of the
cytoskeleton to assure efﬁcient replication. For example, HIV-1
entry is regulated in resting CD4þ T cells by coﬁllin, which
depolymerizes the actin network to overcome this physical
barrier to viral entry (Yoder et al., 2008). Similarly, the actin
binding proteins ERM (Barrero-Villar et al., 2009) and ﬁlamin A
are required for efﬁcient HIV infection (Jimenez-Baranda et al.,
2007). Filamin A has recently been shown to also have a novel
role in Gag intracellular trafﬁcking and distribution at the plasma
membrane (Cooper et al., 2011). In addition, live ﬂuorescent
microscopy showed that viral particles utilize cytoplasmic dynein
and the microtubule network to migrate towards the nucleus
during early HIV infection (McDonald et al., 2002). ITK has been
demonstrated to coordinate spatiotemporal organization of
signaling molecules in response to T cell activation and mediate
events such as actin polymerization and capping upon T cell
receptor engagement and CXCR4 chemokine receptor signaling
(Dombroski et al., 2005; Readinger et al., 2008; Singleton et al.,
2011). We posit that it is the ability of ITK to coordinate
cytoskeleton organization which mediates HIV assembly and
release. It is probable that ITK may be targeting and inﬂuencing
activation of speciﬁc factors that are upstream regulators of the
actin binding proteins ERM and ﬁlamin A such as Vav, RhoA and
cdc42, thus inﬂuencing the clustering of Gag.
An additional mechanism by which ITK may facilitate HIV
release and infection is by coordinating the organization of
protein and lipid domains within the plasma membrane. Proper
formation of the immunological synapse, a structure between
antigen presenting cells and T effector cells which is necessary for
efﬁcient T cell signaling and function, requires ITK (Grasis et al.,
2003; Schaeffer et al., 1999). T cells that lack or express mutant
versions of ITK show impaired TCR induced actin polymerization,
cell polarization and regulation of the signaling events involved in
the cytoskeletal reorganization (Grasis et al., 2003; Schaeffer
et al., 1999). A structure that is similar to the immunological
synapse, the virological synapse, forms between an HIV infected
cell and an uninfected target cell. Virological synapse formation
requires the dynamic redistribution of extracellular receptors on
the surface of the target cell, intracellular proteins and membrane
lipid distribution on the surface of the infected cell, all of whichenables efﬁcient viral particle release. We speculate based on the
changes we observe in Gag distribution and actin polymerization
and capping in juxtaposed infected cells upon inhibition of ITK
activity that ITK may coordinate the generation of functional
virological synapses.
In addition to ITK, other kinases have been implicated as
regulators of HIV replication including Lck (Cheng et al., 1999;
Phipps et al., 1996) and Zap70 (Sol-Foulon et al., 2007). Lck targets
Zap70 and ITK upon TCR engagement. Zap70 and ITK phosphor-
ylation recruits additional T cell kinases which lead to the
formation of a signalasome anchored by LAT and SLP76 assuring
efﬁcient T cell signaling. Furthermore, unlike ITK, Lck has been
shown to directly interact with Gag and inhibiting its activity in T
cells leads to accumulation of intracellular viral particles.
(Strasner et al., 2008). CNX-225 did modestly inhibit Src kinase
Lyn, however, Lyn is not expressed in CD4þ T cells (Corey and
Anderson, 1999; Denny et al., 2000; Olszowy et al., 1995;
Yamanashi et al., 1989) and knocking down the related T cell
restricted tyrosine kinase Fyn had no signiﬁcant impact on HIV
release (data not shown) suggesting that these kinases have a
minimal role in HIV egress. Since Lck can phosphorylate Itk, we
propose that Lck and ITK cooperate to assure that Gag properly
targets and is retained in discrete plasma membrane domains as
well as coordinating the cytoskeletal changes and signalasome
formation which assures efﬁcient HIV egress. It should be noted
that the multifunctional viral protein Nef has been reported to
interact with a number of kinases and signal transduction adapter
proteins; however, overexpression of Nef does not appear to
inﬂuence ITK effects on HIV in our experimental systems, though
a more complete analysis of physical and functional interactions
between Nef and ITK is necessary. Furthermore, other viruses may
co-opt ITK to assure efﬁcient replication in T cells. For example, it
was recently reported that ITK is activated by inﬂuenza A infection
of T cells and enhances virus replication (Fan et al., 2012).
We propose a model in which ITK facilitates HIV release by
coordinating signals that generate a scaffold required for optimal
Gag targeting into proper lipid domains facilitating viral particle
assembly and release. Discovering new therapeutic approaches
which can be used in combination with current retrovirals to
combat HIV replication targeted at the late stages of the viral life
cycle is of high priority. Currently there are a limited number of
compounds that have been identiﬁed as targeting the late stages
of HIV replication, none of which have been approved for treat-
ment. Our ﬁndings would suggest that ITK inhibitors may offer a
potential strategy for reducing viral particle release from infected
T cells. In addition, current treatments for HIV infection target
viral proteins which are highly prone to mutations and selection
for drug-resistant viruses. Targeting cellular proteins required for
HIV replication would be predicted to be less susceptible to
mutations, thus reducing the probability of selection for drug-
resistant viruses. Finally, we have previously shown that inhibi-
tion of ITK blocks HIV infection and replication (Readinger et al.,
2008), coupled with these new ﬁndings that ITK facilitates VLP
formation, targeting ITK could provide a multi-faceted anti-HIV
therapeutic strategy.Materials and methods
Cells, plasmids and transfections
Jurkat E6.1 cells (American Type Culture Collection) were
cultured in RPMI medium 1640 supplemented with 10%
FBS, 100 units/ml penicillin, 100 mg/ml streptomycin, and 0.2 M
L-glutamine. Primary human CD4þ T cells were isolated from
peripheral blood Leukopacks and positively sorted for CD4
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tained in culture in RPMI medium 1640 supplemented with 10%
FBS, 100 units/ml penicillin, 100 mg/ml streptomycin, and 0.2 M
L-glutamine. HEK293T human embryonic kidney cells (American
Type Culture Collection) were cultured in DMEM supplemented
with 10% FBS, 100 units/ml penicillin, 100 mg/ml streptomycin,
and 0.2 M L-glutamine.
Plasmids used in these experiments were Gag-cherry,
p96ZM651 Gag-opt (AIDS Research and Reference Reagent Pro-
gram, NIAID, Drs. Yingying Li, Feng Gao, and Beatrice H. Hahn)
along with 2 mg of eGFP vector, ITK-eGFP fusion protein (gener-
ously provided by Avery August, Cornell University) or mPH ITK-
eGFP (generously provided by Dr. Pamela Schwartzberg, NIH;
(Berg et al., 2005) and DMA(16–99) Gag-cherry. The expression
construct, encoding the codon-optimized Gag-eGFP fusion
protein, was obtained from the NIAID AIDS Reference and
Reagent Program (contributed by Dr. George Pavlakis). HIV-1
Gag-mCherry expression plasmid that expresses a red ﬂuorescent
Gag-mCherry fusion protein has been described previously
(Izquierdo-Useros et al., 2009), and was constructed by swapping
the mCherry sequence for eGFP using BamHI and NotI restricition
enzymes. The MA deﬁcient DMA16-99-Gag-mCherry plasmid is
isogenic to HIV-1 Gag-mCherry, except for the presence of the
indicated in-frame deletion (amino acids 16–99) in the MA coding
region. Brieﬂy, HIV gag sequence was digested with ClaI and
HindIII restriction enzymes to remove the intervening sequence.
The 50 ends were ﬁlled in with the large fragment of Klenow DNA
polymerase to create blunt ends and that were then self-ligated to
create an in-frame deletion of 84 amino acids, and the mutation
(in-frame deletion) veriﬁed by sequencing.
Cells were cotransfected with the indicated plasmids using
calcium phosphate. Media was replaced 3 h post-transfection, and
cells were cultured for 16 h before collecting supernatants or
harvesting cells for assays. Transfections were typically per-
formed in triplicates and the data shown are representative of
at least three independent experiments.
For some experiments cells were cultured for 72 h with ITK
inhibitors BMS509744 (10 mM) (Readinger et al., 2008) or CNX-
225 (1 mM) a covalent small molecule speciﬁc Tec family kinase
inhibitor (Avila Therapeutics) or DMSO vehicle. The structure of
the CNX-225 inhibitor and a summary of its speciﬁc activity are
shown in the supplementary Fig. S1. The ability of CNX-225 to
inhibit Tec kinases was determined using HotSpotSM technology
and utilized radioisotope-based P81 ﬁltration (Reaction Biology
Corporation, Malvern, PA). CNX-225 was dissolved in pure DMSO
to the ﬁnal 1 mM test concentration. Substrates were prepared
and were then added to the substrate solution followed by kinase
addition pre-incubation for 30 min at room temperature. 33P-ATP
(10 mM) was delivered into the reaction mixture to initiate the
reaction and continued for 2 h at room temperature. The reaction
was terminated and any unreacted phosphate was washed away
using 0.1% phosphoric acid prior to detection utilizing a proprie-
tary technology (Reaction Biology Corp.; Malvern, PA, USA). The
study was performed in duplicate and 10 mM staurosporine, a
non-selective, ATP-competitive kinase inhibitor, was used as the
positive control.
HIV infections
Replication competent HXB-PLAP-Nefþ (obtained from the
National Institutes of Health AIDS Research and Reference Rea-
gent program (Chen et al., 1996)) virus stocks were generated
by cotransfecting expression plasmids for HIV-PLAP provirus with
VSG-G envelope as described previously (Readinger et al., 2008).
Jurkat E6.1 cells were infected with VSV-G pseudotyped HXB-PLAP-
Nefþ virus for 4 h and then cultured for 72 h. HIV-1 infected PLAPpositive cells were selected for using Dynal magnetic beads coated
with anti-PLAP antibody (Sigma). The PLAP positive cells were ﬁxed
in 4% paraformaldehyde or treated with BMS509744 (10 mM),
CNX-225 (1 mM) or DMSO for 30 min before ﬁxing and visualizing.
All data shown represent a minimum of at least three independent
infections. Primary human CD4þ_T cells were stimulated with PMA
(10 ng/ml) and PHA (2 mg/ml) for 16 h prior to HIV infection. The
primary human CD4þ T cells were infected via spinocculation using
VSV-G psuedotyped HXB-PLAP-nefþ provirus and polybreene
(8 mg/ml) at 2700RPM for 90 min. After spinocculation the CD4þ
T cells were cultured in fresh media for 24 h. The cells were washed
with PBS 3 prior to CNX-225 (1 mM) or DMSO treatment, cells
were left to culture in the presence of the ITK inhibitor and samples
were taken at 24–96 h post inhibitor treatment for HIV replication
analysis. The data shown is a representative experiment of three
infections from three different donors.Virus like particle assays
HEK293T cells were cotransfected with expression vectors for
Gag and ITK. Following transfection whole cell lysates were
prepared with a lysis buffer (10 mM Tris–HCl, ph 7.4, 150 mM
NaCl, 1 mM EDTA, pH 8.0, 2 mM sodium vanadate, 10 mM sodium
ﬂuoride, 10 mM sodium pyrophosphate, 1% NP-40 1 mM PMSF
and 100 ml of cocktail inhibitor set III), and Gag and ITK expres-
sion was monitored by immunoblots or ﬂuorescent microscopy
using anti-HIV p24 (anti-HIV p24, 183-H12-5C from the National
Institutes of Health AIDS Research and Reference Reagent pro-
gram) and/or anti-ITK antibodies (2F12, Upstate). Cell super-
natants were collected and spun over 20% sucrose cushions at
100,000 g for 1 h at 4 1C to pellet virus like particles (VLPs),
which were resuspended in 1 ml of PBS. Extracellular p24 levels
were measured by ELISA (26).Immunoﬂuorescence microscopy
For imaging transfected HEK293T cells, cells were plated 24 h
prior to transfection on glass and following transfection cells were
ﬁxed with a ﬁnal concentration of 2% paraformaldehyde, and
mounted on glass slides for microscopy analysis.
To image intracellular HIV-1, paraformaldehyde ﬁxed HIV-1
infected Jurkat cells were washed in PBS before permeabilizing for
15 min in 0.1% Triton X-100. Cells were then blocked/enhanced
with Image-IT signal enhancer (Molecular Probes) for 30 min
at room temperature. The cells were washed with ice cold PBS
and stained with primary antibodies against Gag (anti-HIV p24,
183-H12-5C from the National Institutes of Health AIDS Research
and Reference Reagent program), and ITK (anti-ITK [Y401],
AB32039 Abcam) for 1 h at room temperature. Cells were once
again washed extensively with ice cold PBS before staining with
the secondary antibodies. Secondary antibodies used were Alexa
Fluor 594 goat anti-mouse, Alexa Fluor 488 Goat anti-Rabbit
(obtained from Molecular Probes) at 8 mg/ml concentration for
1 h at room temperature. Phalloidin staining was performed with
Alexa Fluor 635 Phalloidin (Molecular Probes) for 30 min in the
dark at room temperature. Cholera Toxin-B staining was per-
formed to identify lipid rafts in living cells for 30 min in the dark
at 4 1C with CT-B FITC (Molecular Probes), washed with PBS then
ﬁxed. DAPI (40,6diamidino2phenylindole from Molecular Probes)
was used as a nuclear stain at a concentration of 300 ng/ml for
10 min in the dark at room temperature. Samples were washed
with ice cold PBS then wet mounted on glass slides for micro-
scopy analysis.
G.M. Schiralli Lester et al. / Virology 436 (2013) 235–243242All microscopy was performed using a Nikon deconvolution
wide-ﬁeld Epiﬂuorescence system at Boston University Cellular
Imaging Core. ImageJ software was used to perform image
analysis including, parallel Iterative Deconvolution 3D analysis,
background subtraction and colocalization analysis via JACoP.
Pearson’s coefﬁcent of colocalization values are indicated as r
values, where perfect colocalization of both signals equals 1. All
images shown are representatives a minimum of three indepen-
dent transfections or HIV-1 infections. Cell quantiﬁcation was
performed by counting at least 60 cells for each set of infections
and over 125 cells for transfection experiments.Acknowledgments
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